Michael Hallek to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Michael Hallek has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.055
-
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Clin Cancer Res. 2018 09 15; 24(18):4371-4379.
Score: 0.028
-
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes. Clin Cancer Res. 2017 Sep 01; 23(17):5292-5301.
Score: 0.026